About erenumab
Calcitonin gene-related peptide receptor blocker
Used for
- Prevention of migraine in adults.
Usual adult dose
Usually 70 mg injected under the skin once monthly; some adults benefit from 140 mg monthly.
Common side effects
- Injection-site reactions
- Constipation
- Muscle cramps or spasms
Important warnings
- Constipation can rarely become severe; bowel obstruction has been reported.
- New or worsening high blood pressure has been reported.
- Serious allergic reactions may occur, including after treatment has stopped.
Pregnancy
Limited information is available; use during pregnancy requires consideration of potential benefits and risks.
Breastfeeding
It is unknown whether erenumab passes into breast milk; discuss benefits and risks with a healthcare professional.
Interactions
- Few clinically important interactions are known.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.